Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Advanced Magnetics, Inc. To Present at the 32nd Annual Deutsche Bank Health Care Conference

Advanced Magnetics, Inc. (Nasdaq: AMAG), today announced that it will participate in
the 32nd annual Deutsche Bank Health Care conference, being held in
Washington D.C. on May 2-3, 2007. Brian J.G. Pereira, MD, President and
Chief Executive Officer of Advanced Magnetics, will present an overview of
the company on Wednesday, May 2, at 8:15 am ET.

Advanced Magnetics, Inc. To Present at the 32nd Annual Deutsche Bank Health Care Conference

Cambridge, MA | Posted on April 23rd, 2007

A live webcast of this presentation will be accessible through the
Investors section of the company's website at .
The event will also be archived on the Advanced Magnetics website for a
limited period of time following the conference.


About Advanced Magnetics, Inc.
Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide
nanoparticles used in pharmaceutical products. As a leader in our field, we
are dedicated to the development and commercialization of our proprietary
nanoparticle technology for use in therapeutic iron compounds to treat
anemia, as well as novel imaging agents to aid in the diagnosis of cancer
and cardiovascular disease.

Ferumoxytol, the company's key product candidate, is being developed
for use as an intravenous (IV) iron replacement therapeutic for the
treatment of iron deficiency anemia in chronic kidney disease. The company
plans to file a New Drug Application for marketing approval of ferumoxytol
with the U.S. Food and Drug Administration during the fourth calendar
quarter of 2007.

Combidex(R), the company's other product under development, is an
investigational functional molecular imaging agent consisting of iron oxide
nanoparticles for use in conjunction with MRI to aid in the differentiation
of cancerous from normal lymph nodes. In March 2005, the company received
an approvable letter from the FDA with respect to Combidex, subject to
certain conditions.

For more information, please click here

Kristen Galfetti


Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanosciences: Genes on the rack October 21st, 2016

Physicists use lasers to capture first snapshots of rapid chemical bonds breaking October 21st, 2016

Nanoparticle vaccinates mice against dengue fever October 21st, 2016

New perovskite solar cell design could outperform existing commercial technologies: Stanford, Oxford team creates high-efficiency tandem cells October 21st, 2016


Leti Scientists Participating in Sessions on Med Tech, Automotive Technologies, MEMS, Si-photonics and Lithography at SEMICON Europa: Teams also Will Demonstrate Technology Advances in Telecom, Data Fusion, Energy, Silicon Photonics and 3D Integration October 18th, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Pokhara (Nepal) all set to host KaSAM-2016: An International Scientific Meeting on Advanced Materials October 15th, 2016

MEMS & Sensors Industry Group Reveals Tech Showcase Finalists --MSIG hosts competition for unique MEMS/sensors demos at MEMS & Sensors Executive Congress, 11/10/16 in Scottsdale, AZ October 11th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project